For example, hormonal therapies such as Tamoxifen have efficacy in breast cancers expressing the oestrogen receptor (ER) while cancers with ERBB2 amplification (HER2) can be treated with HER2 targeting therapies such as trastuzumab (e.g., Herceptin). This evidence concerns the gene ERBB2 and breast cancer.